SCHEMBL2220214

SCHEMBL2220214

O=C(NOCc1ccccc1)c1ncc(CO)c(CO)c1OCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.48
RAB9A P51151 7/20 0.48
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC4 P56524 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC7 Q8WUI4 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC10 Q969S8 1/20 0.39
HDAC11 Q96DB2 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC9 Q9UKV0 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
SGMS2 Q8NHU3 1/20 0.37
LMNA P02545 1/20 0.37
HPGD P15428 1/20 0.37
EGFR P00533 1/20 0.36
MEN1 O00255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12516485 0.85 SGMS2 (0.49) NPC1RAB9ASGMS2LMNAHPGD
SCHEMBL2220527 0.85 LMNA (0.43) NPC1RAB9AKDM4EALDH1A1LMNA
SCHEMBL22283894 0.81 NPC1 (0.41) NPC1RAB9AKDM4EALDH1A1HDAC3
SCHEMBL12516705 0.81 LMNA (0.55) NPC1RAB9AKDM4EALDH1A1SGMS2
SCHEMBL12516470 0.80 APEX1 (0.45) NPC1RAB9AALDH1A1SGMS2LMNA
SCHEMBL2220375 0.80 KMT2A (0.46) NPC1RAB9AKDM4EALDH1A1HDAC1
SCHEMBL12516468 0.80 LMNA (0.44) NPC1RAB9AALDH1A1SGMS2LMNA
SCHEMBL12516715 0.79 TDP1 (0.43) NPC1RAB9AKDM4EALDH1A1LMNA
SCHEMBL13577665 0.79 ERCC1 (0.44) NPC1RAB9ASGMS2LMNAEGFR
SCHEMBL12516704 0.79 NPC1 (0.49) NPC1RAB9AKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8742123-B2 HIV integrase inhibitors from pyridoxine TAIMED BIOLOGICS, INC. (TW) 2014-06-03 US claimed
US-20110178120-A1 HIV INTEGRASE INHIBITORS FROM PYRIDOXINE AMBRILIA BIOPHARMA, INC. (CA) 2011-07-21 US claimed
US-8742123-B2 HIV integrase inhibitors from pyridoxine TAIMED BIOLOGICS, INC. (TW) 2014-06-03 US disclosed
US-20110178120-A1 HIV INTEGRASE INHIBITORS FROM PYRIDOXINE AMBRILIA BIOPHARMA, INC. (CA) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178120-A1 HIV INTEGRASE INHIBITORS FROM PYRIDOXINE PNPO, CCNB1, BLVRB NPC1 3046/4885RAB9A 3692/4885KDM4E 1182/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.